Sorry, you must have the wrong number <a href=" http://madacad.com/methotrexate-pharmacology.pptx#disturbed ">how effective is methotrexate for psoriatic arthritis</a> Rosneft has ambitious development plans, both in upstream and downstream. We believe that its capex will remain high, resulting in negative free cash flow (FCF) before dividends in 2014. Rosneft has, so far in 2013, announced natural gas M&A deals in Russia, including a USD3bn acquisition of its remaining 49% stake in Itera, an independent gas producer, a USD1.4bn acquisition of gas assets of OJSC ALROSA (BB-/RWP) and a USD1.8bn buyout of 19.6% in SeverEnergia from Enel S.p.A. (BBB /RWN). Although these deals should help Rosneft to achieve its production goal of 100bn cubic meters by 2020, they further drain the company's cash.